0001177648 2026-05-11 2026-05-11 0001177648 1 2026-05-11 2026-05-11 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001177648 ENANTA PHARMACEUTICALS INC N/A false S-8 ENANTA PHARMACEUTICALS INC Equity Common stock, $0.01 par value per share true 1600000 14.88 23808000.00 0.0001381 3287.89 23808000.00 3287.89 0.00 3287.89 Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement on Form S-8 (the "Registration Statement") shall also cover any additional shares of the Registrant's common stock, $0.01 par value per share (the "Common Stock") that become issuable under the Registrant's 2019 Equity Incentive Plan (as amended through March 11, 2026) (the "2019 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant's outstanding shares of Common Stock. The Amount Registered covers 1,600,000 shares of the Registrant's Common Stock, which are issuable pursuant to the 2019 Plan. The Proposed Maximum Offering Price Per Share is estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $14.88, the average of the high and low prices of the Registrant's common stock as reported on the Nasdaq Global Select Market on May 6, 2026, which date is within five business days prior to the filing of this registration statement.